Monitoring therapeutic monoclonal antibodies in brain tumor

Bevacizumab induces normalization of abnormal blood vessels, making them less leaky. By binding to vascular endothelial growth factor, it indirectly attacks the vascular tumor mass. The optimal delivery of targeted therapies including monoclonal antibodies or anti-angiogenesis drugs to the target ti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Ait-Belkacem, Rima, Berenguer, Caroline, Villard, Claude, Ouafik, L’Houcine, Figarella-Branger, Dominique, Beck, Alain, Chinot, Olivier, Lafitte, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2014
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622724/
https://ncbi.nlm.nih.gov/pubmed/25484065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.34405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados